🇺🇸 FDA
Patent

US 8193152

Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds

granted A61KA61K31/405A61K38/05

Quick answer

US patent 8193152 (Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds) held by The Board of Regents of the University of Texas System expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/405, A61K38/05, A61P, A61P31/12